This workshop report provides recommendations on the clinical and public health application of inflammatory markers for predicting cardiovascular disease risk.
Informs selective use of inflammatory markers in CVD risk assessment; extends prior evidence with standardized clinical and public health recommendations.
Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice was convened on March 14 and 15, 2002, in Atlanta, Ga, to examine the selection and use of inflammatory markers to predict cardiovascular disease (CVD) risk. Three discussion groups on issues related to laboratory, clinical, and population science were organized. The present report contains a summary of the discussions and recommendations of the clinical practice discussion group.
No takes yet. Share an insight, caveat, or question.
Smith et al. (2004) studied Cardiovascular disease. Inflammatory markers was evaluated. A CDC/AHA workshop examined the selection and use of inflammatory markers to predict cardiovascular disease risk, providing recommendations for clinical and public health practice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: